Emerging therapies in rosacea
- PMID: 24229638
- DOI: 10.1016/j.jaad.2013.04.041
Emerging therapies in rosacea
Abstract
Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.
Keywords: SDD; carvedilol; ivermectin; medical therapy; permethrin; rosacea; subantimicrobial dose doxycycline; subantimicrobial-dose doxycycline.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
